Johnson & Johnson (NYSE:JNJ) Shares Acquired by LPL Financial LLC

LPL Financial LLC grew its stake in Johnson & Johnson (NYSE:JNJ) by 7.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,368,598 shares of the company’s stock after purchasing an additional 94,391 shares during the quarter. LPL Financial LLC’s holdings in Johnson & Johnson were worth $203,757,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Hussman Strategic Advisors Inc. acquired a new position in Johnson & Johnson during the third quarter worth about $1,519,000. Heritage Wealth Advisors boosted its position in Johnson & Johnson by 2.6% during the third quarter. Heritage Wealth Advisors now owns 75,723 shares of the company’s stock worth $11,274,000 after acquiring an additional 1,908 shares during the last quarter. Illinois Municipal Retirement Fund boosted its position in Johnson & Johnson by 379.7% during the third quarter. Illinois Municipal Retirement Fund now owns 46,929 shares of the company’s stock worth $6,987,000 after acquiring an additional 37,146 shares during the last quarter. CWH Capital Management Inc. boosted its position in Johnson & Johnson by 2.5% during the third quarter. CWH Capital Management Inc. now owns 18,694 shares of the company’s stock worth $2,783,000 after acquiring an additional 459 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA acquired a new position in Johnson & Johnson during the third quarter worth about $228,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

In related news, EVP Kathryn E. Wengel sold 16,115 shares of the company’s stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $153.52, for a total transaction of $2,473,974.80. Following the sale, the executive vice president now directly owns 66,658 shares of the company’s stock, valued at approximately $10,233,336.16. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.27% of the stock is owned by corporate insiders.

A number of brokerages have commented on JNJ. ValuEngine raised shares of Johnson & Johnson from a “sell” rating to a “hold” rating in a research note on Monday, August 3rd. Raymond James reaffirmed a “buy” rating on shares of Johnson & Johnson in a research note on Friday. Cantor Fitzgerald lifted their target price on shares of Johnson & Johnson from $168.00 to $180.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 14th. Stifel Nicolaus downgraded shares of Johnson & Johnson from a “buy” rating to a “hold” rating in a research note on Wednesday, August 19th. Finally, Credit Suisse Group lifted their target price on shares of Johnson & Johnson from $163.00 to $168.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 14th. One analyst has rated the stock with a sell rating, four have given a hold rating and ten have issued a buy rating to the company. Johnson & Johnson presently has an average rating of “Buy” and an average target price of $164.93.

Johnson & Johnson stock opened at $146.36 on Friday. The company’s 50 day simple moving average is $145.51 and its 200-day simple moving average is $146.57. The company has a market capitalization of $385.30 billion, a price-to-earnings ratio of 23.01, a price-to-earnings-growth ratio of 3.04 and a beta of 0.69. Johnson & Johnson has a 1 year low of $109.16 and a 1 year high of $157.00. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.48.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings results on Sunday, October 18th. The company reported $2.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.98 by $0.22. Johnson & Johnson had a net margin of 21.01% and a return on equity of 34.64%. The business had revenue of $21.08 billion for the quarter, compared to the consensus estimate of $20.15 billion. During the same period in the previous year, the firm earned $2.12 EPS. The business’s revenue was up 1.7% on a year-over-year basis. Equities analysts expect that Johnson & Johnson will post 7.99 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 24th will be paid a dividend of $1.01 per share. This represents a $4.04 annualized dividend and a yield of 2.76%. The ex-dividend date of this dividend is Monday, November 23rd. Johnson & Johnson’s payout ratio is currently 46.54%.

Johnson & Johnson Company Profile

Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR.

Recommended Story: Cost of Equity For A Business, Investors

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.